Washington: Two new studies have led to the discovery of what researchers call the ‘best’ treatment regimen for Hepatitis C patients.Researchers have shown that treatment with peginterferon alpha-2a (PegIFNá2a) plus ribavirin (RBV) better suppresses the virus to undetectable levels in the blood than treatment with peginterferon alpha-2b (PegIFNá2b) plus RBV.
"Whether our strategy of RBV dosing, which is at variance with the standard of care for PegIFNá2a treatment, is indeed cost-effective, needs to be prospectively assessed through a pharmaco-economy study," added Dr. Colombo.The findings appear in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.ANI
60 days of Narendra Modi government
Glasgow: India`s golden girls shine at CWG
Petrol prices expected to fall by July 31
Delhi auto drivers on a day long strike against Delhi Police